These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16107310)

  • 1. Effects of chronic treatment with fluvoxamine and paroxetine during adolescence on serotonin-related behavior in adult male rats.
    de Jong TR; Snaphaan LJ; Pattij T; Veening JG; Waldinger MD; Cools AR; Olivier B
    Eur Neuropsychopharmacol; 2006 Jan; 16(1):39-48. PubMed ID: 16107310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chronic selective serotonin reuptake inhibitors on 8-OH-DPAT-induced facilitation of ejaculation in rats: comparison of fluvoxamine and paroxetine.
    de Jong TR; Pattij T; Veening JG; Waldinger MD; Cools AR; Olivier B
    Psychopharmacology (Berl); 2005 May; 179(2):509-15. PubMed ID: 15719219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic paroxetine pretreatment on (+/-)-8-hydroxy-2-(di-n-propyl-amino)tetralin induced c-fos expression following sexual behavior.
    de Jong TR; Pattij T; Veening JG; Dederen PJ; Waldinger MD; Cools AR; Olivier B
    Neuroscience; 2005; 134(4):1351-61. PubMed ID: 16019152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of learned helplessness by selective serotonin reuptake inhibitors in rats is not dependent on 5-HT availability.
    Zazpe A; Artaiz I; Labeaga L; Lucero ML; Orjales A
    Neuropharmacology; 2007 Mar; 52(3):975-84. PubMed ID: 17141811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of periadolescent fluoxetine and paroxetine on elevated plus-maze, acoustic startle, and swimming immobility in rats while on and off-drug.
    Vorhees CV; Morford LR; Graham DL; Skelton MR; Williams MT
    Behav Brain Funct; 2011 Oct; 7():41. PubMed ID: 21974752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 8-OH-DPAT, but not deramciclane, antagonizes the anxiogenic-like action of paroxetine in an elevated plus-maze.
    Kõks S; Beljajev S; Koovit I; Abramov U; Bourin M; Vasar E
    Psychopharmacology (Berl); 2001 Jan; 153(3):365-72. PubMed ID: 11271409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors.
    Sánchez C; Hyttel J
    Eur J Pharmacol; 1994 Nov; 264(3):241-7. PubMed ID: 7698161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms.
    Redrobe JP; Bourin M; Colombel MC; Baker GB
    J Psychopharmacol; 1998; 12(4):348-55. PubMed ID: 10065908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of time- and sex-dependent effects of vortioxetine on rat sexual behavior: Possible roles of direct receptor modulation.
    Li Y; Pehrson AL; Oosting RS; Gulinello M; Olivier B; Sanchez C
    Neuropharmacology; 2017 Jul; 121():89-99. PubMed ID: 28414050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the effects of different serotonin reuptake blockers on sexual behaviour of the male rat.
    Mos J; Mollet I; Tolboom JT; Waldinger MD; Olivier B
    Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):123-35. PubMed ID: 10082238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice.
    Guilloux JP; David DJ; Guiard BP; Chenu F; Repérant C; Toth M; Bourin M; Gardier AM
    Neuropsychopharmacology; 2006 Oct; 31(10):2162-72. PubMed ID: 16452992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The selective serotonin re-uptake inhibitors fluvoxamine and paroxetine differ in sexual inhibitory effects after chronic treatment.
    Waldinger MD; van De Plas A; Pattij T; van Oorschot R; Coolen LM; Veening JG; Olivier B
    Psychopharmacology (Berl); 2002 Mar; 160(3):283-9. PubMed ID: 11889497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced reactivity of 5-HT1A receptors in the rat dorsal periaqueductal gray matter after chronic treatment with fluoxetine and sertraline: evidence from the elevated T-maze.
    Zanoveli JM; Nogueira RL; Zangrossi H
    Neuropharmacology; 2007 Mar; 52(4):1188-95. PubMed ID: 17313964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA, or 5-HT, or dual NA/5-HT reuptake inhibition in the rat forced swimming test.
    Rénéric JP; Bouvard M; Stinus L
    Neuropsychopharmacology; 2001 Apr; 24(4):379-90. PubMed ID: 11182533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant-induced adaptive changes in the effects of 5-HT, 5-HT1A and 5-HT4 agonists on the population spike recorded in hippocampal CA1 cells do not involve presynaptic effects on excitatory synaptic transmission.
    Tokarski K; Bijak M
    Pol J Pharmacol; 1996; 48(6):565-73. PubMed ID: 9112695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
    Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
    Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective serotonin reuptake inhibitors reduce the spontaneous activity of dopaminergic neurons in the ventral tegmental area.
    Di Mascio M; Di Giovanni G; Di Matteo V; Prisco S; Esposito E
    Brain Res Bull; 1998 Aug; 46(6):547-54. PubMed ID: 9744293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.
    Rasmussen K; Calligaro DO; Czachura JF; Dreshfield-Ahmad LJ; Evans DC; Hemrick-Luecke SK; Kallman MJ; Kendrick WT; Leander JD; Nelson DL; Overshiner CD; Wainscott DB; Wolff MC; Wong DT; Branchek TA; Zgombick JM; Xu YC
    J Pharmacol Exp Ther; 2000 Aug; 294(2):688-700. PubMed ID: 10900249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?
    Sánchez C; Meier E
    Psychopharmacology (Berl); 1997 Feb; 129(3):197-205. PubMed ID: 9084057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.